‌

Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases

Overview Structured Data Issues Contributors

clinicaltrials.gov/study/NCT02948855

Is a

0

Clinical Study attributes

NCT Number

Health Conditions in Trial

Autoimmune disease

0

0

Trial Recruitment Size

00

Trial Sponsor

Tianjin Medical University Cancer Institute and Hospital

0

Clinical Trial Start Date

2016

0

Primary Completion Date

2018

0

Study Completion Date

2018

0

Clinical Trial Study Type

Observational0

Observational Clinical Trial Type

Case-Only0

Observational Study Perspective

Prospective0

Participating Facility

Tianjin Medical University Cancer Institute and Hospital

0

Official Name

Study on Regulation of LncRNA to Regulatory B Cells(Bregs) Through Notch Pathway in Patients With Thymoma and Autoimmune Diseases0

Last Updated

May 18, 2018

0

Study summary

Initially investigators will find LncRNA which to be able to affect Notch2 signaling pathway; then confirm the relationship between Notch2 and LncRNA, and analysis the regulation mode of LncRNA to Notch2 signaling pathway, and to observe the correlation between LncRNA and thymoma complicated with autoimmune diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.